- Home
- PRTS vs CRVO Comparison
PRTS vs CRVO Comparison
Compare PRTS & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRTS | CRVO |
|---|---|---|
| Founded | 1995 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.4M | 47.7M |
| IPO Year | 2006 | 2011 |
Fundamental Metrics
Financial Performance| Metric | PRTS | CRVO |
|---|---|---|
| Price | $0.82 | $4.73 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $0.50 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 987.0K | 89.8K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,737,974.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 36.29 |
| 52 Week Low | $0.37 | $1.92 |
| 52 Week High | $1.36 | $16.50 |
Technical Indicators
Market Signals| Indicator | PRTS | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 69.09 | 48.54 |
| Support Level | $0.70 | $4.45 |
| Resistance Level | $0.93 | $5.44 |
| Average True Range (ATR) | 0.06 | 0.49 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 70.70 | 70.06 |
Price Performance
Historical ComparisonAbout PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.